John M. Dineen

CIK 1645270 · last filed 2026-06-04

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.45M

Companies

4

Total Filings

39

Lifetime Open-Market Net

$1.53M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CTSH Director 1,827 $52.17 $95.3K $0 23 2026-06-04
LRCX Director 9,135 $366.81 $3.35M $0 3 2025-11-10
Syneos Health, Inc. (SYNH) Delisted Director 0 $42.98 $0 $513.7K 8 2023-09-28
MERRIMACK PHARMACEUTICALS INC (MACK) Delisted Director 100,000 $15.13 $1.51M $1.01M 5 2018-06-15

Recent Filings · Page 2 of 4

39 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-11-12 LRCX Grant (A) +2,950 $0 EDGAR
2024-08-30 CTSH Grant (A) $0 EDGAR
2024-06-06 CTSH Grant (A) $0 EDGAR
2024-05-31 CTSH Grant (A) $0 EDGAR
2024-03-01 CTSH Grant (A) $0 EDGAR
2023-12-04 CTSH Grant (A) $0 EDGAR
2023-11-15 CTSH Exer (M) +1,827 $108.7K EDGAR
2023-11-13 LRCX Grant (A) +455 $0 EDGAR
2023-09-28 Syneos Health, Inc. (SYNH) Delisted Disp (D) −27,492 -$973.0K EDGAR
2023-06-08 CTSH Grant (A) $0 EDGAR
Showing 1120 of 39
Page 2 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.